ƽÌØÎå²»ÖÐ

Event

SEMINAR: Physical Activity, Sedentary Behaviour and Cancer Control: Epidemiologic and Biologic Insights

Monday, March 27, 2017 16:00to17:00

Christine Friedenreich, PhD Scientific Director, Department of Cancer Epidemiology and Prevention Research, CancerControl Alberta, Alberta Health Services - Adjunct Professor and Division Head, Preventive Oncology Departments of Oncology and Community Health Sciences, University of Calgary Physical Activity, Sedentary Behaviour and Cancer Control: Epidemiologic and Biologic Insights

Monday, 27 March 2017 4:00 pm - 5:00 pm – McIntyre Medical Building 3655 promenade Sir William Osler – Meakins Amphitheatre - Room 521 ALL ARE WELCOME

SYNOPSIS: Since the mid-1980s, there have been over 400 observational epidemiologic studies published that have examined the association between physical activity and cancer risk and there is now consistent and strong evidence for this association for more than 10 cancer sites. In addition, research has focused on the role of physical activity in improving coping with cancer treatment, rehabilitation and survival after cancer. More recently, research has focused on the role of sedentary behaviour as a risk factor for both cancer incidence and survival. Evidence is accumulating that too much sitting is an independent risk factor for cancer. In addition, research is now examining the underlying biologic mechanisms that might explain how physical activity and sedentary behaviour are related to both cancer risk and survival. OBJECTIVES: At the end of this seminar, participants will be able to: 1) understand the level of evidence regarding the strength, consistency, coherence and close-response relation between physical activity, sedentary behaviour and cancer risk and survival 2) understand the main biologic mechanisms that may be operative between physical activity and cancer risk and survival 3) understand the gaps in evidence and the areas for future research required in the association between physical activity, sedentary behavior and cancer risk and survival 

SEE PDF FOR DETAILS

Back to top